Education
About Us
Working with TipRanks
Follow Us
Day One Biopharmaceuticals (DAWN)
NASDAQ:DAWN
Day One Biopharmaceuticals (DAWN) Ownership Overview
4.19% Insiders
20.93% Mutual Funds
28.81% Other Institutional Investors
11.57% ETFs
34.50% Public Companies and
Individual Investors
The ownership structure of Day One Biopharmaceuticals (DAWN) stock is a mix of institutional, retail, and individual investors. Approximately 61.31% of the company’s stock is owned by Institutional Investors, 4.19% is owned by Insiders, and 34.50% is owned by Public Companies and Individual Investors.
Recent Hedge Fund Trading Activity
Date | Firm | Activity | Value |
|---|---|---|---|
Jun 30, 2025 | xxxxxxxxxxxxx | $19539 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $653354 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $1442889 | |
Jun 30, 2025 | xxxxxxxxxxxxx | $24200351 |
Top Shareholders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,755,577 | Institution | 5.62% | 41,440,154 | |
| 5,264,021 | Institution | 5.14% | 37,900,951 | |
| 5,043,393 | Institution | 4.92% | 36,312,430 | |
| 3,723,131 | Institution | 3.63% | 26,806,543 | |
| 3,356,154 | Institution | 3.28% | 24,164,309 | |
| 3,103,448 | Institution | 3.03% | 22,344,826 | |
| 2,419,890 | Institution | 2.36% | 17,423,208 | |
| 2,334,142 | Institution | 2.28% | 16,805,822 | |
| 2,034,015 | Insider | 1.99% | 14,644,908 | |
| 1,930,570 | Institution | 1.88% | 13,900,104 |
Top Mutual Fund Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 5,043,393 | Institution | 4.92% | 36,312,430 | |
| 2,419,890 | Institution | 2.36% | 17,423,208 | |
| 2,334,142 | Institution | 2.28% | 16,805,822 | |
| 1,865,766 | Institution | 1.82% | 13,433,515 | |
| 1,572,353 | Institution | 1.54% | 11,320,942 | |
| 1,395,300 | Institution | 1.36% | 10,046,160 | |
| 1,367,692 | Institution | 1.34% | 9,847,382 | |
| 817,126 | Institution | 0.80% | 5,883,307 | |
| 705,301 | Institution | 0.69% | 5,078,167 | |
| 700,604 | Institution | 0.68% | 5,044,349 |
Top ETF Holders
Holder | # of Shares | Type | % Holding | Value |
|---|---|---|---|---|
| 2,386,942 | Institution | 2.33% | 16,827,941 | |
| 1,849,633 | Institution | 1.81% | 13,816,759 | |
| 1,725,036 | Institution | 1.68% | 12,420,259 | |
| 912,712 | Institution | 0.89% | 6,434,620 | |
| 788,102 | Institution | 0.77% | 5,556,119 | |
| 599,840 | Institution | 0.59% | 4,318,848 | |
| 582,715 | Institution | 0.57% | 4,108,141 | |
| 458,277 | Institution | 0.45% | 3,299,594 | |
| 344,650 | Institution | 0.34% | 2,574,536 | |
| 342,290 | Institution | 0.33% | 2,413,145 |
FAQ
Who Owns Day One Biopharmaceuticals (DAWN)?
According to the latest TipRanks data, approximately 28.81% of the company's stock is held by institutional investors, 4.19% is held by insiders, and 34.50% is held by retail investors.
What percentage of Day One Biopharmaceuticals (DAWN) stock is held by institutional investors?
According to the latest TipRanks data, approximately 28.81% of Day One Biopharmaceuticals (DAWN) stock is held by institutional investors.
What percentage of Day One Biopharmaceuticals (DAWN) stock is held by retail investors?
According to the latest TipRanks data, approximately 34.50% of Day One Biopharmaceuticals (DAWN) stock is held by retail investors.
Who owns the most shares of Day One Biopharmaceuticals (DAWN)?
Peter Kolchinsky owns the most shares of Day One Biopharmaceuticals (DAWN).
What is the significance of the ownership structure for a publicly traded company?
The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.